Sarepta Therapeutics | L'Utile Ante Imposte

Prezzo Delle Azioni
18.50
Cambio Giornaliero
1.47 8.63%
Mensile
-21.14%
Annuale
-83.46%
Q1 Previsione
19.71




L'Utile Ante Imposte Cambiamento Data
Acadia Pharmaceuticals USD 44.6M 4.38M 2025-09
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amgen USD 3.92B 2.35B 2025-09
Biogen USD 557.3M 186.7M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Gilead Sciences USD 2.43B 780M 2025-06
Incyte USD 482.31M 75.7M 2025-09
Insmed USD -368.7M 48.26M 2025-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
Moderna USD -187M 631M 2025-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Pfizer USD 3.33B 290M 2025-09
PTC Therapeutics USD -23.07M 47.98M 2025-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -194.05M 347.69M 2025-09
Tectonic Therapeutic USD -19.04M 25K 2025-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Sarepta Therapeutics L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.